J. Lorenz (Lüdenscheid, Germany), D. Bouros (Heraklion, Greece)
Mortality rate of pneumonia in Argentine from 1988 to 1999
C. Saenz, M. Sivori, D. Pascansky (Buenos Aires, Argentina)
|  |
Relationship between arterial carboxyhemoglobin concentrations and other biological inflammatory indicators in patients with bacterial pneumonia
H. Yasuda, M. Yamaya, S. Ebihara, T. Sasaki, H. Sasaki (Sendai, Japan)
| |
Bacterial features of bronchial washing in patients with lung cancer
T. Rikimaru, S. Ide, Y. Sueyasu, M. Ichiki, H. Aizawa (Kurume, Japan)
| |
Significance of febrile episode in patients with lung cancer during therapy - comparison of NSCLC and SCLC patients
S. Yoshiko, R. Gohara, S. Ide, M. Ichiki, T. Rikimaru, H. Aizawa (Kurume, Japan)
| |
The diagnostic value of pleural fluid C-reactive protein level in pleural effusions
H. Celikhisar, A. Celikhisar (Izmir, Turkey)
| |
Legionellosis: Hungarian data and experiences
C. Bognar, E. Tarjan, A. Csohan, M. Kadar, J. Lukacs, E. Szantai, T. Mag, C. Kodmon (Budapest, Hungary)
| |
Etiology of community-acquired pneumonia (CAP) in young hospital patients
E. B. Koroleva, A. M. Borodin, S. V. Hvatova (Nizniy Novgorod, Russia)
| |
Community acquired pneumonia-a study among closed military communities of young people
A. V. Martynova, N. M. Kondrashova, V. B. Turcutyukov (Vladivostok, Russia)
| |
One year analysis of hospital-treated, community-acquired pneumonia (CAP)
E. Renato, T. Viktorija, M. Ema (Golnik, Slovenia)
| |
Management of hospital admitted community acquired pneumonia cases in the hospital for diseases of the chest in Athens
A. Karakatsani, A. Chroneou, M. Agrafiotis, Y. Petasakis, P. Papadima, K. Kostikas, D. Orphanidou (Athens, Greece)
| |
Predictor factors of empirical antimicrobial treatment failure in community-acquired pneumonia
R. Menéndez, A. Torres, on Behalf of Neumofail Group (Valencia, Barcelona, Spain)
| |
The efficacies of macrolides in a murine model of methicillin-resistant staphylococcus aureus hematogenous pulmonary infection
T. Sawai, N. Saku, K. Oshikawa, S. Ohno, Y. Sugiyama (Minamikawachi, Tochigi, Japan)
| |
Our experiences with cefriaxone in the treatment of hospital acquired pneumonias (HAP)
B. Mehic, H. Zutic, Z. Dizdarevic (Sarajevo, Bosnia)
| |
Is it necessary to follow up for one week after the end of antibiotic therapy in community-acquired pneumonia?
K. Fujita, N. Okimoto, H. Ohba, N. Asaoka, Y. Honda, J. Nakamura (Okayama, Japan)
| |
Clinical and pharmacoeconomical assessment of sequential therapy applied in commmunity-aquired pneumonia (CAP) in Internal Medicine Department
G. Klicki, B. Cynowska, J. M. Slomiński (Gdansk, Poland)
| |
Detection of extended spectrum beta lactamases (ESBLs) in enterobacteriaceae isolated from tracheal aspirates
A. Kaftandzieva, V. Kotevska, N. Panovski, G. Jankoska, M. Petrovska, T. Grdanoska (Skopje, Macedonia)
| |
Resistance of respiratory tract Streptococcus pneumoniae strains
V. Kotevska, A. Kaftandzieva, N. Panovski, M. Petrovska, B. Curcic Trajkovska (Skopje, Macedonia)
| |
Penicillin resistance rates for streptococcus pneumoniae strains isolated from lower respiratory tract infections
G. Şenol, O. F. Erer, C. Biçmen, S. Aktogu (Izmir, Turkey)
| |
Treatment results of patients with complicated parapneumonic effusion and empyema
C. Demir, S. Atilla, A. Özcan, S. Özkara (Kecioren, Turkey)
| |
Comparison of treatment methods in empyema
D. Ozol, S. O. Ayik, E. Erdinc (Izmir, Turkey)
| |